Zest has unveiled a new app-based cognitive test designed to screen for the early signs of dementia, as efforts ramp up in ...

Finland’s University of Turku researchers have developed a fluorescent probe for visualising the signalling dynamics in ...

GE HealthCare and PT Kalbe Farma Tbk (Kalbe) have launched the first computed tomography (CT) scanner production facility in ...

With early detection of prostate cancer recognised as a critical part in reducing the disease’s mortality rate, PanGIA ...

Brain-computer interface (BCI) technologies are advancing rapidly, and – as with other innovations like artificial ...

Neuralink has secured $650m in a Series E financing round, marking a milestone in the advancement of its brain implant ...

The company, which was formerly Baxter’s kidney care unit, becoming Vantive after being spun out as part of a $3.5bn ...

A new EU consortium has launched with the aim to reduce pancreatic cancer mortality rate across the continent.

Biocartis’ Idylla EGFR Mutation Test has secured the EU Technical Documentation Assessment and Quality Management System ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation to BiVACOR’s titanium Total Artificial ...

BD is set to commence a multi-centre registry study, XTRACT, of the Rotarex Atherectomy System, for peripheral artery disease ...

Acclaro Medical has completed a Series B funding round, raising $23m, to spur the growth of its flagship products, UltraClear ...